Table 2.

Summary of treatments of Demodex gatoi infestations evaluated in the present case series consisting of 10 cats from six households. The design of the table is adapted from Mueller [20].

No. of household n = 6 (affected cats + unaffected cats)	Cats included n = 11	Drug and dose evaluated	Evaluation criteria	Underlying disease identified	Outcome	Follow-up (months)
1 (3+1)	1A, IB, 1C	Selamectina 6-12 mg/kg every 30 days for 2 months	SS, CE, SB	Allergy (1C)	UE	0
	1A, IB, 1C	Selamectin 6-12 mg/kg every 14 days for 6 months	SS, CE, SB	Allergy (1C)	UE	0
	1A, IB, 1C	Amitrazb 0.0125% solution dips every 7 days for 12 weeks	SS, CE, SB	Allergy (1C)	E	12
2 (1+4)	2A	Selamectin every 30 days for 5 months	CE, SB	None	E	6
3 (2+0)	3A, 3B	Ivermectinc 300 μg/kg SC every 14 days (3 times), followed by selamectin 6-12 mg/kg every 14 days (3 times)	SS, CE	None	UE	0
	3A, 3B	Amitraz 0.0125% solution dips every 7 days for 12 weeks	SS, CE	None	E	24
4 (1+1)	4A	Amitraz 0.0125% solution dips every 7 days for 12 weeks	SS, CE	None	E	12
5 (2+0)	5A, 5B	Selamectin 6-12 mg/kg (once), followed by imidacloprid+moxidectind a month later (once)	CE	None	UE	0
	5A, 5B	Ivermectin 1 mg/kg bw PO every 2 days for 10 weeks	CE, SS, SB	None	E	6
6 (1+5)	6A	Lime sulphur dips 2% weekly for 6 weeks	SS	None	E	6

^aStronghold^® Pfizer Animal Health, bEctodex^®, Intervet/Schering-Plough Animal Health, cIvomec^®, Merial, dAdvocate^® Bayer Animal Health. SC = subcutaneously, PO = perorally, SS = skin scraping or tape strip, CE = clinical evaluation, SB = skin biopsy, E = effective, UE = uneffective